挪威 -
挪威文 -
Statens legemiddelverk
triatec 2.5 mg
sanofi-aventis norge (3) - ramipril - tablett - 2.5 mg
挪威 -
挪威文 -
Statens legemiddelverk
triatec 10 mg
sanofi-aventis norge (3) - ramipril - tablett - 10 mg
挪威 -
挪威文 -
Statens legemiddelverk
kisqali 200 mg
2care4 aps - ribosiklibsuksinat - tablett, filmdrasjert - 200 mg
挪威 -
挪威文 -
Statens legemiddelverk
inspra 25 mg
abacus medicine a/s - eplerenon - tablett, filmdrasjert - 25 mg
挪威 -
挪威文 -
Statens legemiddelverk
inspra 50 mg
abacus medicine a/s - eplerenon - tablett, filmdrasjert - 50 mg
挪威 -
挪威文 -
Statens legemiddelverk
tadalafil accord 5 mg
accord healthcare b.v. - tadalafil - tablett, filmdrasjert - 5 mg
挪威 -
挪威文 -
Statens legemiddelverk
tadalafil aop 20 mg
aop orphan pharmaceuticals gmbh - tadalafil - tablett, filmdrasjert - 20 mg
挪威 -
挪威文 -
Statens legemiddelverk
tadalafil accord 2.5 mg
accord healthcare b.v. - tadalafil - tablett, filmdrasjert - 2.5 mg
欧盟 -
挪威文 -
EMA (European Medicines Agency)
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.